- Home
- OSS vs CRDF Comparison
OSS vs CRDF Comparison
Compare OSS & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSS
- CRDF
- Stock Information
- Founded
- OSS 1998
- CRDF 1999
- Country
- OSS United States
- CRDF United States
- Employees
- OSS N/A
- CRDF N/A
- Industry
- OSS Computer Manufacturing
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OSS Technology
- CRDF Health Care
- Exchange
- OSS Nasdaq
- CRDF Nasdaq
- Market Cap
- OSS 150.4M
- CRDF 144.4M
- IPO Year
- OSS 2018
- CRDF N/A
- Fundamental
- Price
- OSS $5.84
- CRDF $2.23
- Analyst Decision
- OSS Strong Buy
- CRDF Strong Buy
- Analyst Count
- OSS 2
- CRDF 5
- Target Price
- OSS $8.50
- CRDF $11.10
- AVG Volume (30 Days)
- OSS 902.5K
- CRDF 765.0K
- Earning Date
- OSS 11-05-2025
- CRDF 11-06-2025
- Dividend Yield
- OSS N/A
- CRDF N/A
- EPS Growth
- OSS N/A
- CRDF N/A
- EPS
- OSS N/A
- CRDF N/A
- Revenue
- OSS $55,208,915.00
- CRDF $545,000.00
- Revenue This Year
- OSS $11.62
- CRDF N/A
- Revenue Next Year
- OSS $12.81
- CRDF N/A
- P/E Ratio
- OSS N/A
- CRDF N/A
- Revenue Growth
- OSS 4.65
- CRDF N/A
- 52 Week Low
- OSS $1.85
- CRDF $1.90
- 52 Week High
- OSS $7.20
- CRDF $5.64
- Technical
- Relative Strength Index (RSI)
- OSS 50.59
- CRDF 52.32
- Support Level
- OSS $4.98
- CRDF $1.99
- Resistance Level
- OSS $6.30
- CRDF $2.27
- Average True Range (ATR)
- OSS 0.40
- CRDF 0.10
- MACD
- OSS -0.05
- CRDF 0.05
- Stochastic Oscillator
- OSS 37.99
- CRDF 91.67
About OSS One Stop Systems Inc.
One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bressner segment.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.